Neuroleptic malignant syndrome: three episodes with different drugs.
This is an illustrative case of a patient with neuroleptic malignant syndrome whom we believe is the first described in the world's literature to have this syndrome on three occasions, each time after having received a different neuroleptic agent.
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D002746:Chlorpromazine / Q000009:adverse effects; D005260:Female; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D014268:Trifluoperazine / Q000009:adverse effects
D014150:Antipsychotic Agents; D014268:Trifluoperazine; D006220:Haloperidol; D002746:Chlorpromazine